BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

754 related articles for article (PubMed ID: 26419507)

  • 1. Doxorubicin-poly (ethylene glycol)-alendronate self-assembled micelles for targeted therapy of bone metastatic cancer.
    Ye WL; Zhao YP; Li HQ; Na R; Li F; Mei QB; Zhao MG; Zhou SY
    Sci Rep; 2015 Sep; 5():14614. PubMed ID: 26419507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Actively targeted delivery of doxorubicin to bone metastases by a pH-sensitive conjugation.
    Ye WL; Zhao YP; Na R; Li F; Mei QB; Zhao MG; Zhou SY
    J Pharm Sci; 2015 Jul; 104(7):2293-303. PubMed ID: 25980534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alendronate-decorated biodegradable polymeric micelles for potential bone-targeted delivery of vancomycin.
    Cong Y; Quan C; Liu M; Liu J; Huang G; Tong G; Yin Y; Zhang C; Jiang Q
    J Biomater Sci Polym Ed; 2015; 26(11):629-43. PubMed ID: 25994241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(ethylene glycol)-paclitaxel-alendronate self-assembled micelles for the targeted treatment of breast cancer bone metastases.
    Miller K; Clementi C; Polyak D; Eldar-Boock A; Benayoun L; Barshack I; Shaked Y; Pasut G; Satchi-Fainaro R
    Biomaterials; 2013 May; 34(15):3795-806. PubMed ID: 23434349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomicelles based on a boronate ester-linked diblock copolymer as the carrier of doxorubicin with enhanced cellular uptake.
    Xu Y; Lu Y; Wang L; Lu W; Huang J; Muir B; Yu J
    Colloids Surf B Biointerfaces; 2016 May; 141():318-326. PubMed ID: 26874117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual subcellular compartment delivery of doxorubicin to overcome drug resistant and enhance antitumor activity.
    Song YF; Liu DZ; Cheng Y; Liu M; Ye WL; Zhang BL; Liu XY; Zhou SY
    Sci Rep; 2015 Nov; 5():16125. PubMed ID: 26530454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of core cross-linked PCL-PEG-PCL micelles for doxorubicin delivery in vitro.
    Zhang J; Men K; Gu Y; Wang X; Gou M; Guo G; Luo F; Qian Z
    J Nanosci Nanotechnol; 2011 Jun; 11(6):5054-61. PubMed ID: 21770143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxorubicin loaded pH-sensitive micelle targeting acidic extracellular pH of human ovarian A2780 tumor in mice.
    Gao ZG; Lee DH; Kim DI; Bae YH
    J Drug Target; 2005 Aug; 13(7):391-7. PubMed ID: 16308207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tumor accumulation and therapeutic efficacy of doxorubicin carried in calcium phosphate-reinforced polymer nanoparticles.
    Min KH; Lee HJ; Kim K; Kwon IC; Jeong SY; Lee SC
    Biomaterials; 2012 Aug; 33(23):5788-97. PubMed ID: 22591612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facile preparation of core cross-linked nanomicelles based on graft copolymers with pH responsivity and reduction sensitivity for doxorubicin delivery.
    Chen T; Xiao Y; Lu W; Liu S; Gan L; Yu J; Huang J
    Colloids Surf B Biointerfaces; 2018 Jan; 161():606-613. PubMed ID: 29156337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(ethylene glycol) shell-sheddable TAT-modified core cross-linked nano-micelles: TAT-enhanced cellular uptake and lysosomal pH-triggered doxorubicin release.
    Zhang Y; Xiao Y; Huang Y; He Y; Xu Y; Lu W; Yu J
    Colloids Surf B Biointerfaces; 2020 Apr; 188():110772. PubMed ID: 31999965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual targeting curcumin loaded alendronate-hyaluronan- octadecanoic acid micelles for improving osteosarcoma therapy.
    Xi Y; Jiang T; Yu Y; Yu J; Xue M; Xu N; Wen J; Wang W; He H; Shen Y; Chen D; Ye X; Webster TJ
    Int J Nanomedicine; 2019; 14():6425-6437. PubMed ID: 31496695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facile construction of dual-bioresponsive biodegradable micelles with superior extracellular stability and activated intracellular drug release.
    Chen W; Meng F; Cheng R; Deng C; Feijen J; Zhong Z
    J Control Release; 2015 Jul; 210():125-33. PubMed ID: 25987525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEG-oligocholic acid telodendrimer micelles for the targeted delivery of doxorubicin to B-cell lymphoma.
    Xiao K; Luo J; Li Y; Lee JS; Fung G; Lam KS
    J Control Release; 2011 Oct; 155(2):272-81. PubMed ID: 21787818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction-responsive disassemblable core-cross-linked micelles based on poly(ethylene glycol)-b-poly(N-2-hydroxypropyl methacrylamide)-lipoic acid conjugates for triggered intracellular anticancer drug release.
    Wei R; Cheng L; Zheng M; Cheng R; Meng F; Deng C; Zhong Z
    Biomacromolecules; 2012 Aug; 13(8):2429-38. PubMed ID: 22746534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation, characterization and application of star-shaped PCL/PEG micelles for the delivery of doxorubicin in the treatment of colon cancer.
    Gao X; Wang B; Wei X; Rao W; Ai F; Zhao F; Men K; Yang B; Liu X; Huang M; Gou M; Qian Z; Huang N; Wei Y
    Int J Nanomedicine; 2013; 8():971-82. PubMed ID: 23493403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redox and pH-responsive degradable micelles for dually activated intracellular anticancer drug release.
    Chen W; Zhong P; Meng F; Cheng R; Deng C; Feijen J; Zhong Z
    J Control Release; 2013 Aug; 169(3):171-9. PubMed ID: 23306022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonate-functionalized coordination polymer nanoparticles for the treatment of bone metastatic breast cancer.
    He Y; Huang Y; Huang Z; Jiang Y; Sun X; Shen Y; Chu W; Zhao C
    J Control Release; 2017 Oct; 264():76-88. PubMed ID: 28842315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondria and Nucleus Dual Delivery System To Overcome DOX Resistance.
    Cui H; Huan ML; Ye WL; Liu DZ; Teng ZH; Mei QB; Zhou SY
    Mol Pharm; 2017 Mar; 14(3):746-756. PubMed ID: 28146635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly(beta-amino ester) block copolymer micelles for cancer therapy.
    Ko J; Park K; Kim YS; Kim MS; Han JK; Kim K; Park RW; Kim IS; Song HK; Lee DS; Kwon IC
    J Control Release; 2007 Nov; 123(2):109-15. PubMed ID: 17894942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.